rs2234711
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000416.3(IFNGR1):c.-56T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.41 in 1,561,786 control chromosomes in the GnomAD database, including 134,898 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.44 ( 14831 hom., cov: 33)
Exomes 𝑓: 0.41 ( 120067 hom. )
Consequence
IFNGR1
NM_000416.3 5_prime_UTR
NM_000416.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0900
Genes affected
IFNGR1 (HGNC:5439): (interferon gamma receptor 1) This gene (IFNGR1) encodes the ligand-binding chain (alpha) of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2. A genetic variation in IFNGR1 is associated with susceptibility to Helicobacter pylori infection. In addition, defects in IFNGR1 are a cause of mendelian susceptibility to mycobacterial disease, also known as familial disseminated atypical mycobacterial infection. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 6-137219383-A-G is Benign according to our data. Variant chr6-137219383-A-G is described in ClinVar as [Benign]. Clinvar id is 355565.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-137219383-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.61 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNGR1 | NM_000416.3 | c.-56T>C | 5_prime_UTR_variant | 1/7 | ENST00000367739.9 | NP_000407.1 | ||
IFNGR1 | XM_011535793.3 | c.-197T>C | 5_prime_UTR_variant | 1/8 | XP_011534095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFNGR1 | ENST00000367739.9 | c.-56T>C | 5_prime_UTR_variant | 1/7 | 1 | NM_000416.3 | ENSP00000356713 | P2 |
Frequencies
GnomAD3 genomes AF: 0.436 AC: 66223AN: 151998Hom.: 14787 Cov.: 33
GnomAD3 genomes
AF:
AC:
66223
AN:
151998
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.407 AC: 573788AN: 1409670Hom.: 120067 Cov.: 41 AF XY: 0.413 AC XY: 287672AN XY: 696240
GnomAD4 exome
AF:
AC:
573788
AN:
1409670
Hom.:
Cov.:
41
AF XY:
AC XY:
287672
AN XY:
696240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.436 AC: 66326AN: 152116Hom.: 14831 Cov.: 33 AF XY: 0.439 AC XY: 32676AN XY: 74364
GnomAD4 genome
AF:
AC:
66326
AN:
152116
Hom.:
Cov.:
33
AF XY:
AC XY:
32676
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2191
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 64% of patients studied by a panel of primary immunodeficiencies. Number of patients: 56. Only high quality variants are reported. - |
Disseminated atypical mycobacterial infection Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Mycobacterium tuberculosis, protection against Benign:1
protective, no assertion criteria provided | literature only | OMIM | Jun 01, 2009 | - - |
Immunodeficiency 27A Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Helicobacter pylori infection, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jun 01, 2009 | - - |
Hepatitis B virus, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jun 01, 2009 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at